Kalaris Therapeutics announced a delay in preliminary data from its Phase 1b/2 study of TH103 for neovascular age-related macular degeneration to the second half of 2027 due to a manufacturing batch issue. The company completed technology transfer to a commercial-scale manufacturer with successful test batches, supporting a potential Phase 3 start in 2028. Kalaris reported $82.9 million in cash as of September 30, 2026, expected to fund operations into 2028. Despite the delay, the company remains confident in its clinical supply and development progress.
Kalaris Therapeutics' third quarter 2026 financial results and business update provide context for readers. For those following the health sector, here is Pluang's market snapshot as of Nov 10, 2026 18:42 WIB: out of 150 priced health-sector US stocks, 85 rose and 56 fell. Notable movers include ABCL at USD 12.96 with a 1-day change of +3.68% and Pluang order activity of 93% Sell / 7% Buy, LQDA at USD 49.03 with a 1-day change of +2.42% and 97% Sell / 3% Buy, and MRVI at USD 7.83 with a 1-day change of -2.37%.
Duke Robotics has entered a strategic collaboration with Greek security firm CRONOS to commercialize its Insulator Cleaning Drone (IC Drone) technology in Greece. This partnership leverages CRONOS's strong presence in Greece's critical infrastructure...
Alm. Brand A/S repurchased 1,369,397 shares between November 3 and 9, 2026, at an average price of DKK 17.46 per share. This is part of their announced buy-back program totaling up to DKK 593 million, aiming to reduce the number of outstanding shares...
H&R Block has launched the Emerald Advance Loan, a fixed-rate short-term loan up to $1,750 with a 35.90% APR, designed to help families cover year-end expenses without monthly payments. Borrowers repay the loan in full by March 31, 2027, with no impa...
Novartis has secured first place in the 2026 Access to Medicine Index, maintaining its lead since 2024 by excelling across all assessed technical areas, including governance, R&D, and product delivery. The company scored 3.86 out of 5 overall, with a...
Viasat has been awarded a $450 million IDIQ contract by the U.S. Space Force to support the design, development, and sustainment of the Space Data Network Backbone (SDN-B) mission operations center. This network aims to provide resilient, high-capaci...
